Fourteen million patients seek medical care abroad worldwide per year. As per the Medical Travel Platform Medigo, the UAE is ranked as #8 of top destinations for medical tourists. The UAE Medical tourism increases by 5.5% year-over-year, key factors supporting this the UAE in the continues progress in Medical Tourism field are endless, few factors include:
– Increasing sector privatization of the sector in the form of investment and the building state-of-the-art health facilities.
– The support of regulatory authorities in all sectors
– The cultural safety and sensitivity
– The role of the UAE in developing and participating the latest medical and clinical trends.
Growth momentum behind medical tourism in the UAE is expected to continue over the years with country level projects in wellness and medical tourism such as Expo 2021, Dubai Health Experience and Abu Dhabi Health Tourism. The recent global pandemic had an effect on the entire humanity. It is creating a paradigm shift in the importance of lifestyle and wellness. What are the holistic health plans, the genetic implications on humans’ susceptibility to pandemics, modern illnesses and life span? Wellness tourism describes those who are availing of holistic health treatments overseas for better quality of life and higher life satisfaction level.
WELLNESS AND MEDICAL TOURISM
12:15 – 12:30
|The impact of Medical Tourism in Global Healthcare Economy Post Pandemic|
12:30 – 12:45
|Ensuring Cultural Safety in Medical Tourism|
12:45 – 13:00
|The Role of Regulatory Authorities in Legal and ethical challenges on cross border services of Medical Tourism|
13:00 – 13:15
|Global and Regional Outlook of Medical Tourism|
Dr. Saif AlJaibeji | United Arab Emirates
Dr. Saif AlJaibeji | United Arab EmiratesChairman, Sehteq
Saif Aljaibeji is Co-Founder & Chairman of Sehteq, a digital health insurance startup based in Dubai. Saif was the regional CEO at UnitedHealth Group. He worked with Aetna, Daman and AXA Green Crescent prior to that. He also worked as a policy maker at DHA and DGHR.
13:15 – 13:25
|Challenge the Experts|
13:25 – 13:40
|Ensuring Well-being of increasing work-from-home job force|
13:40 – 13:55
|Clinical and Population Genomics in the Middle East|
Dr. Ahmad Abou Tayoun | United Arab Emirates
Dr. Ahmad Abou Tayoun | United Arab EmiratesDirector of the Genetics Laboratory at Al Jalila Children’s Specialty Hospital; Associate professor of genetics – MBRU
Dr. Ahmad is Director of the Genetics Laboratory at Al Jalila Children’s. He completed his doctoral studies (PhD) at Dartmouth College in the USA followed by a fellowship in molecular diagnostics at Dartmouth Medical School. In 2013, he joined Harvard Medical School where he completed his clinical molecular genetics fellowship and, in 2015, became board-certified by the American Board of Medical Genetics and Genomics (ABMGG). Dr. Abou Tayoun is a fellow of the American College of Medical Genetics and Genomics. Prior to joining Al Jalila Children’s, he was a director in the Division of Genomic Diagnostics at the Children’s Hospital of Philadelphia, and also an assistant professor of Pathology and Laboratory Medicine at the University of Pennsylvania Perelman School of Medicine. To support clinicians in various specialties at CHOP, Dr. Ahmad developed genomic sequencing-based diagnostic tests for a range of pediatric disorders. He also developed and published several tools and assays involving next generation sequencing and variant interpretation. Dr. Abou Tayoun is a co-chair of the Clinical Genome Resource (ClinGen) Hearing Loss Expert Group, and is a member of the ClinGen Sequence Variant Interpretation group. In both capacities, Dr. Abou Tayoun is working with international experts to establish guidelines and recommendations for sequence variant interpretation in general, and in the hearing loss disease area specifically.
13:55 – 14:10
|How to enhance the medical tourism in the region|
Dr. Anil Bankar | United Arab Emirates
Dr. Anil Bankar | United Arab EmiratesPhD Medical Tourism Vice President| Business Intelligence, Global Medical Services. United States of America.
Dr Anil Bankar, is the Vice President of Business Intelligence for Global Medical Services. Dr. Bankar has diverse work experience in health and medical tourism, including consulting, strategic planning, research, teaching, and training. As an active and practicing Professor specializing in medical tourism, Dr. Bankar has affiliations with, Gulf Medical University UAE, Dr. Babasaheb Ambedkar Marathwada University, Institute of Clinical Research India, Global Healthcare Network, Web Med Central U.K., Infoline Research, TÜV Rheinland Middle East, Dubai Healthcare City, and Medico Travel Club. He is a member of the Sector Advisory Committee by National Qualification Authority (NQA), Government of UAE. Dr. Bankar is also developing a National Occupational Standard (NOS) for Medical Tourism in association with UAE medical tourism stakeholders. In addition, he was named one of the 100 Most Impactful Healthcare Leaders Award by CMO ASIA. Dr. Anil Bankar received his master’s degree in Tourism Administration and PhD from Dr. Babasaheb Ambedkar Marathwada University. His research thesis is an analytical study, Organization and Management of Medical Tourism. It is the pioneer research study in the country
14:10 – 14:30
|Challenge the Experts|